Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study.
Eric Yuk Fai WanEsther Yee Tak YuWeng Yee ChinFlorence Ting Yan NgShu Ming Cheryl ChiaIan Chi Kei WongEsther Wai Yin ChanCindy Lo Kuen LamPublished in: Diabetes, obesity & metabolism (2020)
HbA1c variability was strongly related to CVD and mortality in patients with diabetes across all age groups. Whilst pursuing optimal HbA1c targets, attention should be given to patients with high HbA1c variability, especially younger patients with good HbA1c control.